Navigation Links
Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
Date:2/27/2009

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as, but not limited to, "look forward to," "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "should" and "could," and similar expressions or words identify forward-looking statements. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. The inclusion of forward-looking statements should not be regarded as a representation by Amicus that any of its plans will be achieved. Any or all of the forward-looking statements in this press release may turn out to be wrong. They can be affected by inaccurate assumptions Amicus might make or by known or unknown risks and uncertainties. For example, with respect to statements regarding the goals, progress, timing and outcomes of ongoing discussions with and submissions to regulatory authorities and the potential goals, progress, timing and results of clinical trials, actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the business of Amicus, including, without limitation: the potential inability to address questions raised by regulatory agencies and to receive approval for phase 2 trial design, the potential that results of clinical or pre-clinical studies indicate that the product candidates are unsafe or ineffective; the potential that the phase 2 trial for AT2220 is not resumed in a timely manner, or at all, and, our dependence on third parties in the conduct of our clinical studies. Further, the results of earlier clinical trials may not be predictive of future results. Additionally, all forward looking statements are subject to other risks detailed in our Annual Report on Form 10-K for the year ended December 31, 2008, and our other public filings with the Securiti
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6csvbs/market_assessment ... "Market Assessment of Respiratory Diagnostics in the United ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service provides ... in the United States ... provides detailed analysis of the current and forecasted ...
(Date:5/21/2015)... Mass. , May 21, 2015  (MUSE ... the Electronic Health Record (EHR) is invaluable in ... Though EHRs are now a requirement and mainstream ... and continuously into the EHR is gaining traction ... Exchange), William Holmes, RN, Site Project Manager & ...
(Date:5/21/2015)... May 21, 2015  Heidrick & Struggles (Nasdaq: ... , leadership consulting and culture shaping ... among global practices announcing the addition of Tim ... office. Dietlin has extensive life ... and across R&D, Medical and Commercial functions to increase ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3Heidrick Increases Healthcare and Life Sciences Expertise 2
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce ... is now the 16th sweetFrog store located in the Lone ... #22 on the Inc. 500 list of fastest growing companies ... in East Texas for 20 years and love the natural ... Jacksonville, and nearby Palestine, sweetFrog locations. “We are really excited ...
(Date:5/22/2015)... Jupiter, FL (PRWEB) May 22, 2015 ... Ed Begley, Jr., scheduled to broadcast on Friday, May ... PST, via Discovery Channel. , In this episode Innovations ... companies get back to business quickly through disaster recovery ... NDPTC, a company that works collaboratively to develop and ...
(Date:5/22/2015)... New York, NY (PRWEB) May 22, 2015 ... of Multifamily Housing, Marc Zuluaga, has been selected by ... innovative engineering. The award winners are featured in the ... given to 40 building industry professionals age 40 and ... to the building community, as well as in other ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 A new ... featuring experts in the field of Physical Therapy. ... that takes the mystery out of physical therapy and ... range of motion for a variety of ailments and ... establish a personalized exercise plan that enhances daily activities ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 In efforts ... patrons, the section containing particular muscles stretches has been ... nearly 50% of stretches now complete, Chunk Fitness envisions ... planned to be filmed and released at a later ... be found here: http://www.chunkfitness.com/stretches . , About the ...
Breaking Medicine News(10 mins):Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2
... and the Chinese Academy of Engineering have advised the government ... and treatment of hepatitis B and tuberculosis diseases. According to ... each year. ,The public was urged for enhanced ... a medical forum in Zhejiang Province in east China. Statistical ...
... following the 9/11 attacks in 2001, when the deadly ... media and two US senators//. The letters contained a virulent ... 17 others. , ,In a bid to ensuring the ... up with scientists at the federal Centers for Disease Control ...
... analysis of U.S prescription use released last week revealed ... for Attention Deficiency Hyperactivity Disorder (ADHD) are 10 times ... themselves. ,In the year 2005 prescription claims of ... researchers, from the prescription manager Medco Health solutions Inc ...
... a study, there may be an increased risk of cancer ... ,Gastroesophageal reflux disease (GERD) is widespread in cancer ... factor for laryngeal cancer. ,The researchers conducted a ... with their counterparts without the disease. The latter matched the ...
... has found that the Iraqi public portrays the highest levels ... solidarity seems to be at an all time high. ... order and security, along with emergence of democracy, which might ... Iraqi nation. The analysis is an outcome of the surveys ...
... coronary artery disease live longer if they receive coronary ... of artery-opening angioplasty or heart medications, according to a ... to 40 percent of patients diagnosed with severe coronary ... not given the opportunity to receive bypass surgery, the ...
Cached Medicine News:Health News:Cell-Wall Carbohydrate in Anthrax Bacterium Holds Promise for New Vaccines 2Health News:Iraqi’s Gripped with Insecurit 2Health News:Iraqi’s Gripped with Insecurit 3Health News:Bypass Surgery, a Better Option than Angioplasty for Severe Heart Patients 2Health News:Bypass Surgery, a Better Option than Angioplasty for Severe Heart Patients 3
... for Medical Records Anywhere. It ... (EMR) software that lets you ... your office, hospital, home using ... offers conversion from hard-copy records ...
... Clinicians HomePage is a comprehensive on-line solution ... you by reducing your time and effort ... concentrate on the clients quality of care. ... a chart audit and shows you everything ...
... expressly to help you manage the ... right combination of EMR software, clinical ... be confident your practice is operating ... more, athenaClinicals seamlessly integrates with athenaNet, ...
... ChartKeeper 5 is Windows-based ... Microsoft programs. Since ChartKeeper 5 ... the embedded text editor you ... Word for creating documentsincluding creating ...
Medicine Products: